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ABSTRACT 
Objective: To optimize aceclofenac fast dissolving tablets employing starch glutamate as novel superdisintegrant by 23
Methods: Starch glutamate was prepared by the esterification process. Starch glutamate physical and micromeritics properties had been evaluated 
and the prepared starch glutamate was used as a superdisintegrant for the formulation of the fast dissolving tablets of aceclofenac by direct 
compression method and optimized by employing 2
factorial design to improve 
bioavailability and enhance patient compliance. 
3
Results: The prepared starch glutamate was amorphous, insoluble in aqueous and organic solvents were tested. Fast dissolving tablets of 
aceclofenac were formulated by employing starch glutamate as a superdisintegrant showed good tablet properties and showed an increased 
dissolution efficiency of the drug. Among all the formulations (F1 to F8), the formulation F8 containing 5% concentration of starch glutamate, 
croscarmellose sodium and, crospovidone as a superdisintegrants showed 99.7±0.15% of drug release within 5 min. Whereas the formulation F2 
containing 5% concentration of starch glutamate, drug release characters were comparable to the formulation F8. Optimized formulation F2 
attained peak plasma concentration within a short period and showed increased relative bioavailability of the drug. 
factorial design. The prepared aceclofenac fast dissolving tablets were evaluated for post 
compression parameters as well as in vitro and in vivo release characteristics. Optimized formulation stability studies were performed at 
accelerated conditions for 6 mo as per ICH and WHO guidelines. 
Conclusion: From the physical properties, disintegration time, in vitro dissolution studies and pharmacokinetic studies, it was concluded that fast 
dissolving tablets of aceclofenac tablets formulated by employing starch glutamate as a superdisintegrant enhanced the dissolution efficiency and 
improved the bioavailability of the drug as compared to the pure drug and stable. 
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INTRODUCTION 
Fast dissolving drug delivery system which consists of fast dissolving 
tablets gaining popularity nowadays [1]. Fast dissolving tablets were 
defined as ‘a solid dosage containing a medicinal substance or active 
ingredient which disintegrates rapidly usually within a matter of 
seconds when placed upon tongue’ [2]. Fast dissolving tablets show 
improved patient compliance by avoiding difficulties in swallowing for 
the all age groups, especially in old age people, children, bedridden 
patients, and mentally disabled patients [3]. Fast dissolving tablets can 
be easily administered without the aid of water and provides accurate 
dosing [4]. Fast dissolving tablets can provide the advantages of a 
liquid dosage form in the solid form [5]. Aceclofenac exhibits potent 
analgesic activity, effective in the treatment of painful inflammatory 
conditions, mostly administered orally. It is broadly prescribed for 
conditions rheumatoid arthritis, osteoarthritis, acute lumbago and 
dental pian [6]. Aceclofenac is a biopharmaceutical classification 
system class-II drug, and drug dissolution is the limiting step for its 
absorption. The work aimed to formulate and characterize fast 
dissolving tablets of aceclofenac by utilizing optimization techniques 
for rapid dissolution of the drug and absorption employing a new 
superdisintegrant i.e., starch glutamate. 
Optimization has been defined as the implementation of systemic 
approaches to achieve the best combination of product and/or 
process characteristics under a given set of conditions [7]. 
Optimization is a phenomenon of finding ‘the best’ possible 
composition or operating conditions. Optimization refers to 
changing one variable at a time, so to obtain a solution to a 
problematic formulation. Optimization technique will help in fixing 
the quantities or levels of excipients [8]. The present study deals 
with an attempt of systemic formulation approach for optimization 
aceclofenac fast dissolving tablets employing a novel 
superdisintegrant i.e. starch glutamate along with other 
superdisintegrants like croscarmellose sodium, and crospovidone. A 
statistical approach i. e 23
MATERIALS AND METHODS 
 factorial design was applied to investigate 
the main and interaction effects of the three formulation variables, 
i.e. starch glutamate (A), croscarmellose sodium (B), and crospovidone 
(C) were independent variables and dissolution efficiency in 5 min and 
percentage dissolved in 5 min were dependent variables in each case 
to find the formula with less disintegration time and more dissolution 
efficiency 5 min. Pharmacokinetic parameters of optimized 
aceclofenac fast dissolving tablets were evaluated by performing in 
vivo studies on male wister rats. The optimized formulation of 
aceclofenac fast dissolving tablets were subjected to accelerated 
stability test by storing the tablets at a temperature of 40±2 ° C and 
75±5% RH for 6 mo. 
Materials 
Glutamic acid, potato starch, acetone, potassium dihydrogen 
phosphate, conc. HCl and Dimethyl sulfoxide, crospovidone, 
croscarmellose sodium, mannitol, microcrystalline cellulose were 
purchased from the SD fine chemicals, Hyderabad and aceclofenac 
pure drug purchased from Yarrow Chem, Mumbai. 
Preparation of starch glutamate 
The starch slurry was prepared by dispersing the starch into 
distilled water. Glutamic acid was taken and it was dissolved in the 
distilled water and this was added to the pre-prepared starch slurry. 
The glutamic acid and starch slurry pH was adjusted to 3.5by using 
10 ml sodium hydroxide. After pH adjustment, this slurry was 
conditioned for 16 h and unreacted glutamic acid was removed by 
washing it with distilled water. The obtained solid mass was dried at 
60 °C temperature to form starch glutamate. Dried starch glutamate 
was passed through #120 sieve and stored in a desiccator. 
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Characterization of starch glutamate 
The prepared starch glutamate was evaluated for the physical and 
micromeritics parameters like solubility, pH, melting point, viscosity, 
swelling index, gelling property, moisture absorption, particle size 
determination, density, compressibility index and angle of repose [9]. 
Fourier transform infrared spectroscopy (FTIR) 
FTIR spectrum of starch glutamate was measured with the help of 
Bruker FTIR (Tokyo, Japan) at the spectrum from 4000-500 cm-1 
Drug and excipient compatibility studies between the starch 
glutamate and aceclofenac drug were done by using Fourier 
transform infrared spectrum (FTIR), and differential scanning 
calorimetry (DSC) [11]. 
[10].  
X-ray diffraction 
X-ray diffraction pattern of the prepared starch glutamate was 
measured by using the X-ray diffractometer (Panalytical spectris Pvt. 
Ltd., Singapore) at full scale 200 [10].  
Scanning electron microscopy 
The surface morphology of the starch and prepared starch glutamate 
were observed with the help of scanning electron microscopy [10].  
Drug and excipient compatibility studies 
Preparation of aceclofenac fast dissolving tablets 
Aceclofenac fast dissolving tablets employing starch glutamate was 
formulated as per 23 factorial design. In this 23
 
 factorial design, three 
were independent variables (Starch glutamate (A), croscarmellose 
sodium (B) and crospovidone (C)) and two were dependent variable 
i.e. dissolution efficiency in 5 min and percent dissolved in 5 min. 
For the formulation of aceclofenac fast dissolving tablets, 
superdisintegrants were selected in two levels, one is lower level, i.e. 
zero and another level is higher level i.e. 5% concentration. To attain 
uniformity in particle size, each ingredient was passed through #100 
mesh. Accurately weighed starch glutamate, crospovidone and 
croscarmellose sodium (superdisintegrants), mannitol (diluent) and 
microcrystalline cellulose (directly compressible vehicle) were 
thoroughly mixed in a mortar by using the pestle. To this mixture, 
aceclofenac drug was added and finally talc (glidant), magnesium 
stearate (lubricant) was added to this powder mixture and 
compressed into tablets by using eight-station compression machine 
(Karnawathi Machineries Pvt, Ltd., Ahmedabad, India). The 
composition of the different formulation of aceclofenac fast 
dissolving tablets were shown in table 1 [12]. 
Table 1: Formulae of aceclofenac fast dissolving tablets 
Ingredients (mg/tablet) F1 F2 F3 F4 F5 F6 F7 F8 
Aceclofenac 100 100 100 100 100 100 100 100 
Starch glutamate (A) --- 25 --- 25 --- 25 --- 25 
Croscarmellose sodium (B) --- --- 25 25 --- --- 25 25 
Crospovidone (C) --- --- --- --- 25 25 25 25 
Mannitol 130 105 105 80 105 80 80 55 
Microcrystalline cellulose 250 250 250 250 250 250 250 250 
Talc 10 10 10 10 10 10 10 10 
Magnesium stearate 10 10 10 10 10 10 10 10 
Total weight 500 500 500 500 500 500 500 500 
 
Evaluation tests for the aceclofenac fast dissolving tablets 
Hardness test 
Hardness test of the tablet was done by using the Monsanto 
hardness tester. Tablets were placed in the hardness tester and the 
breaking point was recorded. The average breaking point of 10 
tablets was noted, from this hardness of the tablet evaluated [13]. 
Friability test 
Friability test was performed in Roche fribilator. In this, previously 
weighed 20 tablets were placed in the fribilator and rotated at 
25rpm speed for 100 revolutions and again tablets were weighed 
after completion of the set revolutions. Then, percentage weight loss 
was calculated by using the following formula [14]. 
 
Where W (initial) = initial weight of the tablets 
W (final) = Final weight of the tablets 
Drug content uniformity test 
Ten tablets were weighed and powdered, a quantity powder 
equivalent to 10 mg weight of the aceclofenac was taken and diluted 
with pH 7.4 phosphate buffer absorbance was measured at 276 nm 
with UV-Vis spectrophotometer (Shimadzu) [14]. 
Wetting time 
Wetting time is the time required to wet tablet completely. Five 
Whatman tissue papers were placed in a petri dish, and in this 10 ml 
amaranth solution was added. Later tablet was placed on the tissue 
paper and time required for the tablet to wet completely was noted 
[15].  
Water absorption ratio 
The water absorption ratio was noted by pre-weighing the tablet 
before placing it on tissue paper which was kept in petri-dish 
containing 6 ml of distilled water and allowed it to wet completely 
and the wet weight of the tablet was noted after complete 
absorption of water. The water absorption ratio of the tablet was 
measured by using the following formula [15].  
 
Where  
R = water absorption ratio 
Wd 
W
= weight of the tablet after water absorption 
e 
In vitro disintegration time 
= weight of the tablet before water absorption. 
In vitro disintegration test was performed by using USP 
disintegration apparatus basket rack assembly. Phosphate buffer 
(pH 7.4) was used as a disintegration medium which is maintained 
at a temperature of 37±0.2 °C. Six tablets were selected randomly 
and placed one in each of the tubes of the basket rack assembly 
which contain the disintegration media and the time was noted in 
seconds for the complete disintegration of the tablet without leaving 
any residue [16].  
In vitro dissolution studies 
In vitro dissolution studies were performed by using 8 station 
dissolution test apparatus (Electro TDL-08L) which was fitted with 
the paddle. Fast dissolving tablets were placed in the dissolution 
media i. e 7.4 pH phosphate buffer (900 ml) at a temperature of 
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37±0.5 °C and 50rpm. The samples (5 ml each time) were 
withdrawn at the predetermined time intervals 5, 10, 15, 30, 45 and 
60 min and filtered through 0.45µ membrane filter. The samples 
were analyzed at 274 nm by using UV-Vis spectrophotometer 
(Shimadzu) [17]. 
Factorial design 
The polynomial regression algorithm equation was drawn to co-
relate the independent variables, i.e. superdisintegrants starch 
glutamate (A), croscarmellose sodium (B), crospovidone (C) and 
dependent variables like percent dissolved in 5 min and dissolution 
efficiency in 5 min. Contour plots and surface plots were drawn with 
the help of Design Expert 7.11 version software. Based on the results 
of statistical analysis, the optimum formulation was selected. 
In vivo studies 
The optimized formulation of aceclofenac fast dissolving tablets 
employing starch glutamate was tested on male Wister rats along 
with the pure drug. Male Wister rats were selected as an animal 
model. This pre-clinical study protocol was approved by the 
Institutional Animal Ethical Committee, GITAM Institute of 
Pharmacy, GITAM (Deemed to be University), and Visakhapatnam 
(Approval No: 1287/PO/Re/S/09/CPCSEA). Male Wister rats with 
body weight 200-250g were housed in a wire cage by keeping three 
rats in one cage and provided with free access to food and water. 
These animal cages were placed in a clean room with controlled 
room temperature (20-25 °C) and animals were exposed to 12hr 
light cycle and 12hr dark cycle in a day. 
Male Wister rats with a bodyweight of 200-250g selected randomly 
and divided into two groups each group containing 6 rats. In two 
groups, one group treated with the pure drug (10 mg/Kg body 
weight in 0.5% CMC) and another group was treated with an 
optimized formulation (10 mg/Kg body weight in 0.5% CMC). Before 
the commencement of the study, rats were fastened for 12 h and 
during the study, they had limited access to food and water. A two-
way crossover design was selected for the study, the dose was 
administered to the Wister rats by dispersing the drug in distilled 
water and through the oral feeding pipe. After drug administration, 
blood samples were collected from a lateral tail vein of the rat at 
specified time intervals, i.e. zero (pre-dose), 0.5, 1, 2, 3, 4, 5, 6 and 7th
Stability studies 
 
hour by anesthetizing the rats with mild ether. These blood samples 
were collected in the microcentrifuge tubes which containing 6 mg 
of EDTA (anti-coagulant) to prevent the blood clotting in 
microcentrifuge tubes. Plasma from these blood samples was 
separated by centrifugation at a speed of 5000 rpm for 25 min and 
these plasma samples were stored at-20 °C until further analysis. 
The plasma samples were analyzed using a validated HPLC method 
to determine pharmacokinetic parameters. 
As per ICH and WHO guidelines optimized formulation of 
aceclofenac fast dissolving tablets were subjected to accelerated 
stability test by storing the tablets at a temperature of 40±2 ° C and 
75±5% RH for 6 mo in HDPE bottles. Before and after storing for 
6months these samples were analyzed for change in physical 
properties and drug release characteristics [18]. 
RESULTS AND DISCUSSION 
The synthesized novel superdisintegrant starch glutamate was found 
to be insoluble in all aqueous and organic solvents which were tested 
and pH of 1% aqueous dispersion is 2.88. Starch glutamate was free-
flowing and amorphous. It was having a high swelling index, i.e. 1200, 
which helps in the quick breakup of the tablet into smaller particles 
and helps in faster disintegration and increase rate of dissolution of 
the drug. Starch glutamate did not exhibit any gelling nature with good 
compressibility index and excellent flow property. Results of physical 
and micromeritics properties were given in table 2. 
FTIR spectrum of potato starch and starch glutamate was analyzed 
and shown in fig. 1, 2. In the FTIR spectrum of starch glutamate, a peak 
was observed at 1619.29 cm-1
The compatibility of the prepared starch glutamate with aceclofenac 
was evaluated by Fourier transform infrared spectroscopy (FTIR), 
and differential scanning calorimetry (DSC). The FTIR spectrum of 
aceclofenac and aceclofenac-starch glutamate was shown in fig. 6, 7. 
FTIR spectrum of the aceclofenac showed characteristic bands at 
1769.91(-COO), 1719.91(-C=O), 1581.86(-C=C), 3274.64(-OH), 
3317.22 (-NH) and 747.44(Aromatic-Cl) whereas in the FTIR 
spectrum of aceclofenac-starch glutamate exhibited same 
characteristic bands at 1770.42(-COO), 1719.34(-C=O), 1584.46(-
C=C), 3276.76(-OH), 3317.22 (-NH) and 751.12(Aromatic-Cl). From 
the FTIR spectra, it was concluded that starch glutamate did not 
show any interaction with the selected drug. 
, characteristic of the ester group. 
Whereas no peak was observed in the FTIR spectrum of potato starch, 
from this it was concluded that an ester (starch glutamate) was 
formed when potato starch was treated with glutamic acid. X-ray 
diffraction pattern of the starch glutamate was evaluated to know its 
molecular structure and shown in fig. 3. X-ray diffraction pattern of 
starch glutamate did not show any characteristic peaks indicating the 
amorphous nature of the novel superdisintegrant. Scanning electron 
microscopy (SEM) of the starch and starch glutamate was shown in fig. 
4, 5 respectively. SEM of the starch glutamate indicates the amorphous 
nature of it. From the results of physical, micromeritics and structural 
properties of starch glutamate it was concluded that starch glutamate 
has all the characteristic properties of an ideal superdisintegrant, so it 




Fig. 1: Fourier transform infrared (FTIR) spectrum of potato starch 
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Table 2: Physical and micrometric properties of starch glutamate 
Parameter Observation 
Solubility Insoluble in all aqueous and organic solvent (alcohol, dichloromethane, chloroform, acetone and, petroleum ether) 
pH (1% aqueous dispersion) 2.88 
Melting point Charred at 325 °C 
Viscosity (1%w/v aqueous 
dispersion) 
1.08cps 
Swelling index 1200 
Gelling property It did not exhibit any gelling property as that of potato starch. 
Moisture absorption 4.4% 
Particle size 158μm (80/120 mesh) 
Density 0.584g/cc 
Bulk density 0.562g/cc 
Angle of repose 27.47 ° 
Compressibility Index 14.23% 
 
 
Fig. 2: Fourier transform infrared (FTIR) spectrum of starch glutamate 
 
 
Fig. 3: XRD spectrum of starch glutamate 
 
 
Fig. 4: Scanning electron microscopy of potato starch 
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Fig. 5: Scanning electron microscopy of starch glutamate 
 
DSC thermograms of the aceclofenac and aceclofenac–starch 
glutamate were shown in fig. 8, 9 and it was found that DSC 
thermogram of the aceclofenac showed a sharp exothermic peak at 
152.57 °C and this same sharp exothermic peak was found in the 
DSC thermogram of aceclofenac-starch glutamate too at 152.51 °C. 
The exothermic peaks in this region correspond to the melting point 
of the aceclofenac drug i.e. 149-153 °C, from this it was evident that 
starch glutamate did not show any interaction with the selected 
drug.  
FTIR and DSC studies of starch glutamate indicated that the 
prepared superdisintegrant i.e. starch glutamate was compatible. 
 
 
Fig. 6: FTIR spectrum of aceclofenac pure drug 
 
 
Fig. 7: FTIR spectrum of aceclofenac-starch glutamate 
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Fig. 8: DSC thermogram of aceclofenac pure drug 
 
 
Fig. 9: DSC thermogram of aceclofenac-starch glutamate 
 
Evaluations tests for aceclofenac fast dissolving tablets 
Hardness 
The hardness of aceclofenac fast dissolving tablets was found to be 
in between 3.7±0.02 to 3.9±0.02 Kg/cm2
Friability 
and passed the official IP 
hardness test. Hardness results were tabulated in table 3. All the 
formulations of aceclofenac possessed sufficient strength which 
helps to withstand handling, packing, storage, and transportation 
without getting broken. 
Friability of aceclofenac fast dissolving tablets were found to be in-
between 0.11±0.011 to 0.12±0.012%, which have passed the official 
IP friability test. Friability results were tabulated in table 3. All the 
tablets possessing good mechanical strength as per IP and 
withstands mechanical shocks during handling and transportation.  
Drug content uniformity 
Drug content uniformity of aceclofenac fast dissolving tablets was 
found to be in between 98.28±0.51 to 99.41±0.21 mg/tab. Drug 
content uniformity results were tabulated in table 3. All the 
aceclofenac fast dissolving tablets passed the official IP drug content 
uniformity test (i.e. 85 to 115% of the average content).  
Wetting time and water absorption ratio 
Water absorption ratio and wetting time of aceclofenac fast 
dissolving tablets depends on the superdisintegrant used in the 
formulation. Wetting time and water absorption ratio results of 
aceclofenac fast dissolving tablets were given in table 3. From the 
results, it was concluded that the formulation which contains the 
novel superdisintegrant have less wetting time and more water 
absorption ratio compared to the formulation with no 
superdisintegrant added. The wetting time and water absorption 
ratio of formulations F8 and F2 were found to better than the 
aceclofenac fast dissolving tablets formulated by Hazarika et al. [19]. 
In vitro disintegration time 
In vitro disintegration times of the aceclofenac fast dissolving tablets 
were given in table 3. From the results, it was concluded that 
disintegration time depends on the concentration of the 
superdisintegrants added to the formulation. Among all the 
formulations, the formulation (F8) which containing the 5% 
concentration of each superdisintegrant i.e. starch glutamate, 
croscarmellose sodium and crospovidone resulted into less 
disintegration time i.e. 4±0.58 sec. whereas the formulation F2 with 
a novel superdisintegrant i.e. starch glutamate in the concentration 
range of 5% was also comparable to the formulation F8. Both the 
formulations F2 and F8 showed less disintegration time compared 
to the aceclofenac tablets prepared employing βCD and Kolliphor 
HS15 by Chowdary et al. [20]. 
In vitro dissolution studies 
The formulation F8, formulated by employing 5% concentration of 
starch glutamate, 5% concentration of croscarmellose sodium and 5% 
concentration of crospovidone showed 99.7±0.15% of drug release 
within 5 min, whereas formulation F2 with novel superdisintegrant i.e. 
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starch glutamate in the concentration range of 5% was also 
comparable to the formulation F8. Therefore, when compared to F8, 
F2 was found to be more economical with single novel 
superdisintegrant i.e. starch glutamate and it was considered as good 
fast dissolving formulations of aceclofenac which was found to better 
than the aceclofenac fast dissolving tablets formulated by Hazarika et 
al.[19]. Cumulative percentage drug release and dissolution 
parameters of the aceclofenac fast dissolving tablets were given in 
table 4 and represented in fig. 10, 11. ANOVA results of disintegration 
time (table 5.1), wetting time (table 5.2), water absorption ratio (table 
5.3) and dissolution efficiency in 5 min (table 5.4) were given and from 
these results it was concluded that, individual effects of starch 
glutamate (A), croscarmellose sodium (B) and crospovidone (C) as 
well as combined effects of AB, BC, AC, and ABC, were showed 
significant effect on the wetting time, water absorption ratio, 
disintegration time and on dissolution efficiency in 5 min. 
  










ratio (%) n±SD 
Disintegration time 
(sec) n±SD 
F1 3.8±0.02 0.11±0.012 98.28±0.51 191±2.65 0.29±0.05 318±1.00 
F2 3.9±0.02 0.12±0.011 99.1±0.53 8±1.00 9.81±0.10 23±1.00 
F3 3.8±0.02 0.12±0.011 99.21±0.25 7±1.00 1.40±0.03 8±1.00 
F4 3.9±0.02 0.11±0.013 98.74±0.32 6±0.58 1.25±0.12 9±1.00 
F5 3.7±0.02 0.12±0.011 99.41±0.21 27±3.06 0.98±0.02 25±1.00 
F6 3.8±0.02 0.12±0.011 99.22±0.04 8±1.00 0.92±0.00 7±1.00 
F7 3.9±0.01 0.12±0.012 99.11±0.37 32±1.00 1.60±0.43 26±2.65 
F8 3.9±0.02 0.11±0.011 99.16±0.12 4±1.00 1.96±0.02 4±0.58 
 *All the values are expressed as mean±SD, where n=3, SD: Standard Deviation. 
 
Table 4: Dissolution parameters of the aceclofenac fast dissolving tablets formulated using starch glutamate as superdisintegrant 
Time (min) F1 F2 F3 F4 F5 F6 F7 F8 
PD 7.3±1.05 5 86.0±1.00 98.0±1.03 99.3±0.12 96.4±0.50 99.05±0.03 47.0±1.06 99.7±0.15 
DE5 6.4±0.23 % 85.2±0.20 93.6±1.19 94.9±0.12 94.3±0.51 94.5±0.61 47.4±0.57 94.9±0.72 




13.3 14.6 14.8 14.7 14.7 7.4 14.8 
K1 (min-1 0.020±0.001 ) 0.535±0.144 0.804±0.104 1.004±0.033 0.399±0.011 0.931±0.007 0.144±0.014 1.126±0.147 




26.75 40.2 50.2 19.95 46.55 7.2 56.3 
All the values are expressed as mean±SD, where n=3, SD: Standard Deviation. PD5–Percent dissolved in 5 min, DE5%-Dissolution efficiency in 5 min, 
K1–
 
First order rate constant. 
 
Fig. 10: Dissolution profile of aceclofenac fast dissolving tablets prepared by employing starch glutamate (F1-F8) (n=3, mean±SD) 
 
 
Fig. 11(A): Time vs log percent undissolved plots for aceclofenac fast dissolving tablets prepared by employing starch glutamate (F1-F4) 
(n=3, mean±SD) 
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Fig. 11(B): Time vs log percent undissolved plots for aceclofenac fast dissolving tablets prepared by employing starch glutamate (F5-F8) 
(n=3, mean±SD) 
 
Table 5.1: ANOVA of disintegration time of aceclofenac fast dissolving tablets formulated by employing starch glutamate 
Source of variation d. f Sum of squares Mean S. S  Variance ratio  Result 
Replicates 2 3.583 1.79 1.087 P>0.05 
Treatments 7 243439.29 34777.04 21095.26 P<0.05 
Starch glutamate (A) 1 41917.04 41917.04 25426.28 P<0.05 
Croscarmellose sodium (B) 1 39935.04 39935.04 24224.03 P<0.05 
Starch glutamate x croscarmellose sodium (AB) 1 31901.04 31901.04 19350.72 P<0.05 
Crospovidone (C) 1 32930.04 32930.04 19974.90 P<0.05 
Starch glutamate x crospovidone (AC) 1 24130.04 24130.04 14636.94 P<0.05 
Croscarmellose sodium x crospovidone (BC) 1 38801.04 38801.04 23536.16 P<0.05 
Starch glutamate x croscarmellose sodium x crospovidone (ABC) 1 33825.04 33825.04 20517.79 P<0.05 
Error 14 23.08 1.65 -- -- 
Total 23 -- -- -- -- 
All the values are expressed as mean±SD, where n=3, SD: Standard Deviation. d. f-Degree of freedom, *S. S-Sum of Square, *M. S. S-Mean Sum of 
Square, P>0.05 indicates non-significance, P<0.05 Indicates Significance, ANOVA-Analysis of Variance. 
 
Table 5.2: ANOVA of wetting time of aceclofenac fast dissolving tablets formulated by employing starch glutamate 
Source of variation d. f Sum of squares Mean S. S  Variance ratio  Result 
Replicates 2 18.75 9.38 5.340 P<0.05 
Treatments 7 85398.29 12199.76 6948.60 P<0.05 
Starch glutamate (A) 1 20126.04 20126.04 11463.16 P<0.05 
Croscarmellose sodium (B) 1 12927.04 12927.04 7362.84 P<0.05 
Starch glutamate x croscarmellose sodium (AB) 1 11223.38 11223.38 6392.48 P<0.05 
Crospovidone (C) 1 7385.04 7385.04 4206.29 P<0.05 
Starch glutamate x crospovidone (AC) 1 7038.38 7038.38 4008.84 P<0.05 
Croscarmellose sodium x crospovidone (BC) 1 13113.38 13113.38 7468.97 P<0.05 
Starch glutamate x croscarmellose sodium x crospovidone (ABC) 1 13585.04 13585.04 7737.62 P<0.05 
Error 14 24.58 1.76 -- -- 
Total 23 -- -- -- -- 
All the values are expressed as mean±SD, where n=3, SD: Standard Deviation. d. f-Degree of freedom, *S. S-Sum of Square, *M. S. S-Mean Sum of 
Square, P>0.05 indicates non-significance, P<0.05 Indicates Significance, ANOVA-Analysis of Variance. 
 
Table 5.3: ANOVA of water absorption ratio of aceclofenac fast dissolving tablets formulated by employing starch glutamate 
Source of variation d. f Sum of squares Mean S. S  Variance ratio  Result 
Replicates 2 0.109 0.05 2.461 P>0.05 
Treatments 7 199.79 28.54 1288.97 P<0.05 
Starch glutamate (A) 1 35.09 35.09 1584.71 P<0.05 
Croscarmellose sodium (B) 1 12.56 12.56 567.09 P<0.05 
Starch glutamate x croscarmellose sodium (AB) 1 32.06 32.06 1448.00 P<0.05 
Crospovidone (C) 1 19.91 19.91 899.20 P<0.05 
Starch glutamate x crospovidone (AC) 1 30.92 30.92 1396.27 P<0.05 
Croscarmellose sodium x crospovidone (BC) 1 31.14 31.14 1406.54 P<0.05 
Starch glutamate x croscarmellose sodium x crospovidone (ABC) 1 38.10 38.10 1720.75 P<0.05 
Error 14 0.31 0.02 -- -- 
Total 23 -- -- -- -- 
All the values are expressed as mean±SD, where n=3, SD: Standard Deviation. d. f-Degree of freedom, *S. S-Sum of Square, *M. S. S-Mean Sum of 
Square, P>0.05 indicates non-significance, P<0.05 Indicates Significance, ANOVA-Analysis of Variance. 
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Table 5.4: ANOVA of dissolution efficiency in 5 min of aceclofenac fast dissolving tablets formulated by employing starch glutamate 
Source of variation d. f Sum of squares Mean S. S  Variance ratio  Result 
Replicates 2 0.61 0.31 0.788 P>0.05 
Treatments 7 22364.00 3194.86 8252.40 P<0.05 
Starch glutamate (A) 1 6134.40 6134.40 15845.32 P<0.05 
Croscarmellose sodium (B) 1 948.78 948.78 2450.73 P<0.05 
Starch glutamate x croscarmellose sodium (AB) 1 341.26 341.26 881.48 P<0.05 
Crospovidone (C) 1 976.65 976.65 2522.71 P<0.05 
Starch glutamate x crospovidone (AC) 1 396.09 396.09 1023.12 P<0.05 
Croscarmellose sodium x crospovidone (BC) 1 7729.27 7729.27 19964.91 P<0.05 
Starch glutamate x croscarmellose sodium x crospovidone (ABC) 1 5837.52 5837.52 15078.47 P<0.05 
Error 14 5.42 0.39 -- -- 
Total 23 -- -- -- -- 
All the values are expressed as mean±SD, where n=3, SD: Standard Deviation. d. f-Degree of freedom, *S. S-Sum of Square, *M. S. S-Mean Sum of 
Square, P>0.05 indicates non-significance, P<0.05 Indicates Significance, ANOVA-Analysis of Variance. 
 
Factorial design 
Independent variables, i.e. superdisintegrants like starch glutamate 
(A), croscarmellose sodium (B) and crospovidone (C) whereas 
response variables (dependent variables) i.e. percent dissolved in 5 
min and dissolution efficiency in 5 min has been co-related by using 
a polynomial regression algorithm. Polynomial equation of percent 
dissolved in 5 min and dissolution efficiency in 5 min was given as 
equation 1 and 2 respectively. 
 
 
The interaction between the superdisintegrants starch glutamate 
(A), croscarmellose sodium (B), and crospovidone (C) and their 
effect on percent dissolved in 5 min and dissolution efficiency in 5 
min given in the following table 6. 
The response surface plots and contour plots indicate the relationship 
between the concentration of superdisintegrants on the percent 
dissolved in 5 min and dissolution efficiency in 5 min. Table 7 describes 
the relationship between the concentration of superdisintegrant on the 
percent dissolved in 5 min and dissolution efficiency in 5 min. 
 
Table 6: Interactions between superdisintegrants and their effect on percent dissolved in 5 min and dissolution efficiency in 5 min 
Interactions between superdisintegrants Effect on 
Percent dissolved in 5 min Dissolution efficiency in 5 min 
Starch glutamate X croscarmellose sodium (AB) - - 
Starch glutamate X crospovidone (AC) - - 
Croscarmellose sodium X crospovidone (BC) - - 
Starch glutamate (A) + + 
Croscarmellose sodium (B) + + 
Crospvidone (C) + + 
Starch glutamate X croscarmellose Sodium X crospovidone (ABC) + + 
‘-’which means negative effect; ‘+’ which means a positive effect, contour plots and surface response plots were drawn based on the interaction 
effects on percent dissolved in 5 min and dissolution efficiency in 5 min. Contour plots and surface plots were given in fig. 12.1-12.6. 
 
 
Fig. 12.1: (A) Response surface plot (B) Contour plot of aceclofenac fast dissolving tablets (Effect of starch glutamate and croscarmellose 
sodium on percent dissolved in 5 min) 
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Fig. 12.2: (A) Response surface plot (B) Contour plot of aceclofenac fast dissolving tablets (Effect of starch glutamate and crospovidone on 
percent dissolved in 5 min) 
 
 
Fig. 12.3: (A) Response surface plot (B) Contour plot of aceclofenac fast dissolving tablets (Effect of crospovidone and croscarmellose 
sodium on percent dissolved in 5 min) 
 
 
Fig. 12.4: (A) Response surface plot (B) Contour plot of aceclofenac fast dissolving tablets (Effect of starch glutamate and croscarmellose 
sodium on dissolution efficiency in 5 min) 
 
 
Fig.12.5: (A) Response surface plot (B) Contour plot of aceclofenac fast dissolving tablets (Effect of starch glutamate and crospovidone on 
dissolution efficiency in 5 min) 
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Fig. 12.6: (A) Response surface plot (B) Contour plot of aceclofenac fast dissolving tablets (Effect of crospovidone and croscarmellose 
sodium on dissolution efficiency in 5 min) 
 
Table 7: Relation between concentrations of superdisintegrant on percent dissolved in 5 min and dissolution efficiency in 5 min 
Interactions between 
superdisintegrants 
Relation established Suitable concentration 
range On percent dissolved in 5 min On dissolution efficiency in 5 min 
Starch glutamate X croscarmellose 
sodium (AB) 
Linear Linear 4-5% 
Starch glutamate X crospovidone (AC) Linear Linear 4-5% 
Croscarmellose sodium X crospovidone 
(BC) 
Non-linear Linear 4-5% 
 
Optimal formula 
The formulation F8, which was formulated employing 5% 
concentration of starch glutamate, 5% concentration of 
croscarmellose sodium and 5% concentration of crospovidone 
showed more percent dissolved in 5 min and dissolution efficiency 
in 5 min. Formulation F2 containing a single superdisintegrant i.e. 
starch glutamate in the concentration range of 5% is also 
comparable to the formulation F8. Therefore, F2 can be considered 
as an optimized formulation which was more economical. 
Pharmacokinetics studies 
Pharmacokinetic studies revealed that the optimized formulation 
(F2) of aceclofenac fast dissolving tablets reached peak plasma 
concentration in less time (1 sec) and with increased absorption and 
relative bioavailability (182.77) when compared to pure drug. These 
results were in agreement with the results obtained by Dahiya et al. 
[21]. Summary of pharmacokinetic parameters was shown in table 8. 
Stability studies 
Stability studies indicated that the optimized formulation (F2) of 
aceclofenac fast dissolving tablets employing starch glutamate was 
stable at accelerated conditions and found comparable with the 
aceclofenac tablets prepared by Sanjay S. Patel et al. [22]. Various 
physical properties of the optimized formulation were shown in 
table 9 and the dissolution profile of optimized formulation F2, 
before and after storage of six months was shown in fig. 13. 
 





Optimized aceclofenac fast dissolving tablet formulation F2 employing starch 
glutamate (B) 
Cmax 1.58  (µg/ml) 8.7 
Tmax 4.0 (h) 1.0 
AUC0-7h 9.072 (µg. h/ml) 31.825 
AUC0-∞ 18.687  (µg. h/ml) 34.155 
BA (%) 100 182.77 
Ka (h-1 0.695 ) 0.728 
Kel (h-1 0.1144 ) 0.4711 
MRT (h) 0.98 0.96 
 















3.9±0.02 0.12±0.011 99.1±0.53 8±1.00 9.81±0.10 23.0±1.00 
Aceclofenac (F2) 
(after stability) 
3.9±0.01 0.13±0.010 99.0±0.32 8±1.01 9.80±0.01 22.0±1.02 
All the values are expressed as mean±SD, where n=3, SD: Standard Deviation. 
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Fig. 13: Dissolution profiles of aceclofenac fast dissolving tablets F2 before and after storage for 6 mo during the stability study 
 
CONCLUSION 
The novel superdisintegrant i.e. starch glutamate which was 
synthesized from esterification of potato starch and glutamic acid is 
found to be best and is used as a superdisintegrnat for the 
preparation of fast dissolving tablets. Optimized aceclofenac fast 
dissolving tablets were prepared by using a 5% concentration of 
starch glutamate were subjected to in vitro and in vivo studies and 
stability studies showed the best drug release and increased relative 
bioavailability. Based on the above studies, the superdisintegrant 
nature of starch glutamate was proved. 
ABBREVIATIONS 
FTIR-Fourier Transform Infrared Spectra, DSC-Differential Scanning 
Calorimetry, SEM-Scanning Electron Microscopy, HPLC-High 
Performance Liquid Chromatography, ICH-International Conference 
On Harmonisation, WHO-World Health Organization. 
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